Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPER: Dalteparin for Postpartum VTE Prophylaxis
NCT01274637Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Mar 2011
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of dalteparin in venous thromboembolism (VTE), sponsored by Ottawa Hospital Research Institute. Started Mar 2011; status: completed.
02
Drugs
dalteparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01274637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01274637.